Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

CUSIP: 16385C104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Ordinary Shares / American Depositary Shares
Shares outstanding
412,914,375
Total 13F shares
3,085,723
Share change
+208,731
Total reported value
$58,690,000
Price per share
$19.02
Number of holders
11
Value change
+$1,761,108
Number of buys
7
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 16385C104?
CUSIP 16385C104 identifies CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2021

As of 30 Jun 2021, Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,085,723 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Ikarian Capital, LLC, MARSHALL WACE, LLP, BOOTHBAY FUND MANAGEMENT, LLC, Marshall Wace North America L.P., MEITAV DASH INVESTMENTS LTD, Virtu Financial LLC, Spire Wealth Management, MORGAN STANLEY, and UBS Group AG. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.